Introduction & Objective: Wearable devices have demonstrated potential in encouraging physical activity (PA) in the general population. This study is to investigate sociodemographic factors linked to the use of wearable devices and assess the influence of the wearable device use on PA among adults with diabetes.

Methods: Data were extracted from the Health Information National Trend Survey 6, covering from March to November 2022. The study included 1,020 adults with diabetes (the survey did not specify the diabetes types). PA levels were self-reported, and logistic regression was employed to examine factors associated with the use of wearable devices and the achievement of a weekly 150-minute moderate-intensity PA (MPA).

Results: About 57% were female, with a mean age of 62.9 years (SD=13.4) (Non-Hispanic White, 47.7 %; Non-Hispanic Black, 22.3%; Hispanic 21.4%). About 25% reported using wearable devices, and 27% engaged in ≥ 150 minutes of MPA per week. Hispanic respondents exhibited significantly higher wearable device use than Non-Hispanic White respondents (OR 1.73, 95% CI, 1.12-2.67). Individuals with an annual household income ≥ $75,000 (OR 4.23, 95% CI, 2.34-7.63) were 4.23 times more likely to use wearable devices; however, household income levels were not significantly associated with MPA. Females (OR 0.60, 95% CI, 0.43-0.82) and individuals with a body mass index ≥ 30kg/m2 (OR 0.54, 95% CI, 0.40-0.74) were less likely to achieve 150 minutes of MPA per week. Importantly, those utilizing wearable devices were 1.72 times more likely to report ≥ 150 minutes of MPA per week (OR 1.72, 95% CI, 1.21-2.43).

Conclusion: The use of wearable devices may have potential to enhance PA among individuals with diabetes. Future efforts promoting PA should take into account the socioeconomic factors linked to wearable adoption. Also, strategies that ensure the equitable adoption of wearable devices should be explored and discussed for individuals with diabetes.

Disclosure

M. Lee: None. S. Nam: None.

Funding

This study is supported by NIH/NIDDK (5R01DK132069).

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.